COVID-19 Clinical Guidance For the Cardiovascular Care Team
Current COVID-19 Clinical Context • The overall case fatality rate (CFR) of COVID-19 based on published reports remains low at 2.3%, with data indicating lower overall Chinese mortality outside of the outbreak epicenter in Hubei, Chinai • Beyond China, real-time reporting indicates CFRs between 2.7%...
| Formato: | Published Article |
|---|---|
| Publicado: |
2020-03-09
|
| Materias: | |
| Acceso en línea: | https://www.acc.org/~/media/665AFA1E710B4B3293138D14BE8D1213.pdf https://hdl.handle.net/20.500.12663/858 |
| id |
PAO-20.500.12663-858 |
|---|---|
| record_format |
dspace |
| spelling |
2020-03-29T16:29:25Z 2020-03-29T16:29:25Z 2020-03-09 https://www.acc.org/~/media/665AFA1E710B4B3293138D14BE8D1213.pdf https://hdl.handle.net/20.500.12663/858 Current COVID-19 Clinical Context • The overall case fatality rate (CFR) of COVID-19 based on published reports remains low at 2.3%, with data indicating lower overall Chinese mortality outside of the outbreak epicenter in Hubei, Chinai • Beyond China, real-time reporting indicates CFRs between 2.7% (Iran) and 0.5% (South Korea); however, this information is provisional and likely to changeii • More than 80% of infected patients experience mild symptoms and recover without intensive medical interventioni • However, morbidity and mortality increase significantly with age, rising to 8.0% among patients 70-79 and 14.8% in patients over 80 in large-scale Chinese case reportingi • Published case reports from the Chinese Centers for Disease Control indicate patients with underlying comorbid conditions have a heighted risk for contracting COVID-19 and a worse prognosis; depending on the report, between 25% and 50% of COVID-19 patients present with underlying conditionsi,iii • Case fatality rates for comorbid patients are materially higher than the average population:i o Cancer: 5.6% o Hypertension: 6.0% o Chronic respiratory disease: 6.3% o Diabetes: 7.3% o Cardiovascular disease: 10.5%. English COVID-19 Neoplasms Cardiovascular Disease Hypertension Diabetes Chronic Respiratory Disease Risk Factors Noncommunicable Diseases Coronavirus Infectious Diseases COVID-19 Clinical Guidance For the Cardiovascular Care Team United States. American College of Cardiology United States Clinical characterization and management Published Article Save Lives / Salvar Vidas |
| elec_str_mv |
Organización Panamericana de la Salud |
| collection |
Organización Panamericana de la Salud |
| title |
COVID-19 Clinical Guidance For the Cardiovascular Care Team |
| spellingShingle |
COVID-19 Clinical Guidance For the Cardiovascular Care Team COVID-19 Neoplasms Cardiovascular Disease Hypertension Diabetes Chronic Respiratory Disease Risk Factors Noncommunicable Diseases Coronavirus Infectious Diseases |
| title_short |
COVID-19 Clinical Guidance For the Cardiovascular Care Team |
| title_full |
COVID-19 Clinical Guidance For the Cardiovascular Care Team |
| title_fullStr |
COVID-19 Clinical Guidance For the Cardiovascular Care Team |
| title_full_unstemmed |
COVID-19 Clinical Guidance For the Cardiovascular Care Team |
| title_sort |
covid-19 clinical guidance for the cardiovascular care team |
| topic |
COVID-19 Neoplasms Cardiovascular Disease Hypertension Diabetes Chronic Respiratory Disease Risk Factors Noncommunicable Diseases Coronavirus Infectious Diseases |
| topic_facet |
COVID-19 Neoplasms Cardiovascular Disease Hypertension Diabetes Chronic Respiratory Disease Risk Factors Noncommunicable Diseases Coronavirus Infectious Diseases |
| publishDate |
2020-03-09 |
| format |
Published Article |
| description |
Current COVID-19 Clinical Context • The overall case fatality rate (CFR) of COVID-19 based on published reports remains low at 2.3%, with data indicating lower overall Chinese mortality outside of the outbreak epicenter in Hubei, Chinai • Beyond China, real-time reporting indicates CFRs between 2.7% (Iran) and 0.5% (South Korea); however, this information is provisional and likely to changeii • More than 80% of infected patients experience mild symptoms and recover without intensive medical interventioni • However, morbidity and mortality increase significantly with age, rising to 8.0% among patients 70-79 and 14.8% in patients over 80 in large-scale Chinese case reportingi • Published case reports from the Chinese Centers for Disease Control indicate patients with underlying comorbid conditions have a heighted risk for contracting COVID-19 and a worse prognosis; depending on the report, between 25% and 50% of COVID-19 patients present with underlying conditionsi,iii • Case fatality rates for comorbid patients are materially higher than the average population:i o Cancer: 5.6% o Hypertension: 6.0% o Chronic respiratory disease: 6.3% o Diabetes: 7.3% o Cardiovascular disease: 10.5%.
|
| url |
https://www.acc.org/~/media/665AFA1E710B4B3293138D14BE8D1213.pdf https://hdl.handle.net/20.500.12663/858 |
| _version_ |
1737882869775204352 |